Company History

 

Achievements

  • July 2015 Grant for world first laboratory grown tendon received 
  • March 2015 Orthocell receives approval for Celgro® dental study
  • Feb 2015 First patients in Hong Kong treated with Ortho-ATI® therapy
  • Jan 2015 US patent for Celgro® received 
  • Jan 2015 Chinese patent for Celgro technology granted
  • Nov 2014 Orthocell grow first human tendons in laboratory
  • Sept 2014 Patent received for Ortho-ATI® and rotator cuff injuries
  • Aug 2014 Orthocell listed on ASX
  • Aug 2014 Orthocell generates first royalties from China
  • Feb 2012  Phase I Study results for Ortho-ATI® published in supplement  ’Science Translational Medicine’
  • June 2011 Patent granted for ‘Method of Manufacture of ATI’ in USA, Australia, Singapore and New Zealand
  • April 2011 Commencement of Erasmus MC clinical study in the Netherlands for mid substance Achilles tendon injuries
  • Oct 2010 Successful Australian Research Council Linkage grant awarded in conjunction with partner/collaborating organisation(s); University of Western Australia, Griffith University Qld., Sir Charles Gairdner Hospital W.A., University of Auckland, N.Z. Project Title: “Bio-engineered Bio-scaffolds for Achilles Tendinopathy Treatment”
  • Sept 2010 Ethics approval received for Level I randomised double-blinded study for the treatment of Achilles tendons using Orthocell’s Ortho-ATI® treatment
  • Feb 2010 Orthocell’s Ortho-ATI® and Ortho-ACI® products launched into the Australian market
  • Dec 2009 TGA license to manufacture Human Tissue granted (Lic.# MI-19052008-LI-02420)
  • Sept 2008 Phase I clinical trial ethics committee approvals received
  • June 2007 GMP Facility opening by the Honourable Minister for Energy; Resources; Industry and Enterprise Francis Logan
  • March 2007 GMP laboratory facility construction completed
  • July 2006 Licence and acquisition agreements finalised over key intellectual property from University of Western Australia
  • June 2006 Seed capital secured company incorporation